HomeBLRX • NASDAQ
add
BioLine RX Ltd - ADR
$4.04
Makalipas ang Oras ng Trabaho:(3.47%)-0.14
$3.90
Sarado: Set 12, 5:20:00 PM GMT-4 · USD · NASDAQ · Disclaimer
Nakaraang pagsara
$4.01
Sakop ng araw
$3.87 - $4.11
Sakop ng taon
$2.30 - $26.80
Market cap
16.96M USD
Average na Volume
37.83K
P/E ratio
-
Dividend yield
-
Mga balita tungkol sa merkado
Mga Financial
Income Statement
Kita
Net na kita
| (USD) | Hun 2025info | Y/Y na pagbabago |
|---|---|---|
Kita | 304.00K | -94.36% |
Gastos sa pagpapatakbo | 2.54M | -75.31% |
Net na kita | -3.94M | -914.05% |
Net profit margin | -1.30K | -14,548.72% |
Kita sa bawat share | 0.00 | — |
EBITDA | -2.13M | 59.85% |
Aktuwal na % ng binabayarang buwis | — | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (USD) | Hun 2025info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 28.16M | -29.71% |
Kabuuang asset | 43.27M | -33.02% |
Kabuuang sagutin | 23.20M | -54.17% |
Kabuuang equity | 20.07M | — |
Natitirang share | 2.56B | — |
Presyo para makapag-book | 401.00 | — |
Return on assets | -13.27% | — |
Return on capital | -17.12% | — |
Cash Flow
Net change in cash
| (USD) | Hun 2025info | Y/Y na pagbabago |
|---|---|---|
Net na kita | -3.94M | -914.05% |
Cash mula sa mga operasyon | -177.00K | 98.44% |
Cash mula sa pag-invest | -3.70M | 57.15% |
Cash mula sa financing | 1.60M | -93.29% |
Net change in cash | -1.85M | -150.84% |
Malayang cash flow | 2.10M | 136.56% |
Tungkol
BioLineRx Ltd., or BioLine, is a publicly traded drug development company. Headquartered in Israel, its shares are traded on the NASDAQ Capital Market and on the Tel Aviv Stock Exchange. Wikipedia
Itinatag
2003
Website
Mga Empleyado
28
